搜尋





搜尋





市場行情
/
股票
/
glue
/

Monte Rosa Therapeutics Inc

GLUE

添加自選

16.520USD

-6.160-27.16%

收盤 07-31 16:00（美東）報價延遲15分鐘

1.40B總市值

虧損本益比TTM

Monte Rosa Therapeutics Inc

16.520

-6.160-27.16%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

GLUE 利潤表

您可以在這裡找到Monte Rosa Therapeutics Inc的年度或季度收入報告，以深入了解Monte Rosa Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

營業總收入

-95.04%4.21M

-95.41%2.78M

38.54%12.77M

394.01%23.19M

7882.05%84.93M

--60.65M

--9.22M

--4.70M

--1.06M

----

營業收入

-95.04%4.21M

-95.41%2.78M

38.54%12.77M

394.01%23.19M

7882.05%84.93M

--60.65M

--9.22M

--4.70M

--1.06M

----

營業費用

32.65%54.24M

10.19%52.50M

27.98%45.74M

3.78%38.75M

13.56%40.89M

36.66%47.64M

-3.31%35.74M

0.31%37.34M

5.11%36.01M

7.31%34.86M

30.34%36.97M

36.69%37.22M

40.97%34.26M

38.92%32.49M

42.75%28.36M

50.26%27.23M

111.25%24.30M

95.94%23.39M

211.12%19.87M

235.86%18.12M

167.97%11.50M

--11.94M

--6.39M

--5.40M

--4.29M

研發費用

36.90%44.07M

8.01%41.98M

32.81%36.68M

9.26%30.65M

19.11%32.19M

43.23%38.87M

-2.44%27.62M

-3.51%28.05M

1.01%27.03M

9.12%27.14M

32.63%28.31M

38.88%29.08M

49.34%26.75M

37.16%24.87M

41.20%21.34M

43.03%20.94M

93.20%17.91M

83.82%18.13M

176.22%15.12M

201.48%14.64M

143.07%9.27M

--9.86M

--5.47M

--4.86M

--3.81M

折舊攤銷及損耗

-0.93%2.03M

3.44%2.13M

-0.38%2.10M

3.16%2.13M

7.79%2.05M

11.65%2.06M

14.67%2.10M

48.09%2.06M

58.33%1.90M

72.52%1.85M

77.54%1.83M

56.47%1.39M

59.36%1.20M

32.26%1.07M

77.49%1.03M

90.36%889.00K

174.82%753.00K

262.78%809.00K

240.35%582.00K

548.61%467.00K

285.92%274.00K

--223.00K

--171.00K

--72.00K

--71.00K

其他營業費用

----

---6.03M

---5.32M

----

營業利潤

-213.62%-50.03M

-482.31%-49.72M

-24.31%-32.98M

52.35%-15.55M

226.01%44.04M

137.30%13.00M

28.24%-26.53M

12.30%-32.64M

-2.01%-34.95M

-7.31%-34.86M

-30.34%-36.97M

-36.69%-37.22M

-40.97%-34.26M

-38.92%-32.49M

-42.75%-28.36M

-50.26%-27.23M

-111.25%-24.30M

-95.94%-23.39M

-211.12%-19.87M

-235.86%-18.12M

-167.97%-11.50M

---11.94M

---6.39M

---5.40M

---4.29M

淨非營業利息收入（費用）

利息收入

62.58%5.59M

42.16%3.69M

-5.05%2.75M

16.34%3.07M

40.83%3.44M

9.59%2.59M

29.86%2.89M

14.55%2.64M

0.21%2.44M

18.99%2.37M

123.37%2.23M

266.56%2.30M

1535.57%2.44M

--1.99M

--997.00K

--628.00K

--149.00K

----

出售證券收益

-104.62%-8.00K

-2600.00%-50.00K

81.05%-29.00K

2722.64%1.39M

-72.10%173.00K

100.26%2.00K

-666.67%-153.00K

43.01%-53.00K

387.04%620.00K

-175.27%-779.00K

-57.14%27.00K

-169.40%-93.00K

-325.00%-216.00K

-328.79%-283.00K

250.00%63.00K

145.27%134.00K

-47.25%96.00K

-34.69%-66.00K

110.34%18.00K

-1054.84%-296.00K

3133.33%182.00K

---49.00K

---174.00K

--31.00K

---6.00K

特殊收入（費用）

----

--0.00

100.00%0.00

--0.00

---960.00K

---7.68M

--0.00

-固定資產出售收益

-100.00%0.00

--0.00

--59.00K

--0.00

-100.00%0.00

----

--0.00

100.00%0.00

--24.00K

-100.00%0.00

--0.00

---16.00K

--0.00

--125.00K

----

稅前利潤

-193.18%-44.45M

-395.34%-46.08M

-27.20%-30.26M

63.08%-11.10M

249.62%47.71M

146.89%15.60M

31.47%-23.79M

14.09%-30.06M

0.48%-31.89M

-8.10%-33.27M

-27.07%-34.71M

-32.18%-34.99M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

所得稅

-93.67%52.00K

-97.27%59.00K

-4574.65%-3.18M

375.79%1.20M

890.36%822.00K

9936.36%2.16M

-58.24%71.00K

32.63%252.00K

--83.00K

---22.00K

--170.00K

--190.00K

----

除稅後利潤

-194.92%-44.50M

-443.34%-46.13M

-13.50%-27.08M

59.44%-12.29M

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

持續經營利潤

-194.92%-44.50M

-443.34%-46.13M

-13.50%-27.08M

59.44%-12.29M

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

其他淨損益

----

---2.19M

----

歸属于母公司的淨利潤

-194.92%-44.50M

-443.34%-46.13M

-13.50%-27.08M

59.44%-12.29M

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

歸屬普通股東的淨利潤

-194.92%-44.50M

-443.34%-46.13M

-13.50%-27.08M

59.44%-12.29M

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

基本每股收益

-178.07%-0.45

-429.57%-0.54

-12.97%-0.33

64.84%-0.15

207.40%0.57

128.04%0.16

58.46%-0.29

40.21%-0.43

18.15%-0.53

7.29%-0.58

-19.79%-0.70

-25.47%-0.71

-26.41%-0.65

-24.94%-0.63

-35.52%-0.58

-38.75%-0.57

-86.14%-0.51

-14.01%-0.50

-192.64%-0.43

-239.03%-0.41

-185.35%-0.28

---0.44

---0.15

---0.12

---0.10

稀釋每股收益

-178.83%-0.45

-429.57%-0.54

-12.97%-0.33

64.84%-0.15

206.35%0.57

128.04%0.16

58.46%-0.29

40.21%-0.43

18.15%-0.53

7.29%-0.58

-19.79%-0.70

-25.47%-0.71

-26.41%-0.65

-24.94%-0.63

-35.52%-0.58

-38.75%-0.57

-86.14%-0.51

-14.01%-0.50

-192.64%-0.43

-239.03%-0.41

-185.35%-0.28

---0.44

---0.15

---0.12

---0.10

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Monte Rosa Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 GLUE 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Monte Rosa Therapeutics Inc 財年末的營收是多少？



Monte Rosa Therapeutics Inc 2025 財年營收為 123.67M，高於上一財年的 75.62M。

Monte Rosa Therapeutics Inc 最近一個季度的營收是多少？



Monte Rosa Therapeutics Inc 最近一個季度的營收為 4.21M，同比增長 -95.04%。

Monte Rosa Therapeutics Inc 全年的淨利潤是多少？



Monte Rosa Therapeutics Inc 2025 財年淨利潤為 -38.63M。

Monte Rosa Therapeutics Inc 上一季度的淨利潤是多少？



Monte Rosa Therapeutics Inc 最近一個季度的淨利潤為 -44.50M。

Monte Rosa Therapeutics Inc 年度營業利潤是多少？



Monte Rosa Therapeutics Inc 2025 財年的營業利潤為 -54.21M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。